You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

FROVATRIPTAN SUCCINATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Frovatriptan Succinate patents expire, and when can generic versions of Frovatriptan Succinate launch?

Frovatriptan Succinate is a drug marketed by Amneal Pharms Co, Glenmark Pharms Ltd, Mylan, and Renata. and is included in four NDAs.

The generic ingredient in FROVATRIPTAN SUCCINATE is frovatriptan succinate. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Frovatriptan Succinate

A generic version of FROVATRIPTAN SUCCINATE was approved as frovatriptan succinate by GLENMARK PHARMS LTD on March 11th, 2016.

  Try a Trial

Summary for FROVATRIPTAN SUCCINATE
Drug patent expirations by year for FROVATRIPTAN SUCCINATE
Pharmacology for FROVATRIPTAN SUCCINATE
Anatomical Therapeutic Chemical (ATC) Classes for FROVATRIPTAN SUCCINATE
Paragraph IV (Patent) Challenges for FROVATRIPTAN SUCCINATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FROVA Tablets frovatriptan succinate 2.5 mg 021006 1 2011-03-09

US Patents and Regulatory Information for FROVATRIPTAN SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 211292-001 Nov 6, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Renata FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 213891-001 Apr 6, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glenmark Pharms Ltd FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 204730-001 Mar 11, 2016 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 202931-001 Aug 28, 2014 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.